Peripheral neuropathy in patients using GLP-1 receptor agonists: emerging clinical concerns
Background: Glucagon-like peptide-1 receptor agonists have become widely used in the management of diabetes mellitus and obesity due to their efficacy in glycemic control and weight reduction. Although generally considered safe, the rapid metabolic and weight changes associated with these agents have raised questions r...